A novel BCL11A polymorphism influences gene expression, therapeutic response and epilepsy risk: A multicenter study

BACKGROUND: Genetic factors have been found to be associated with the efficacy and adverse reactions of antiseizure medications. BCL11A is an important regulator of the development of neuronal networks. However, the role of BCL11A in epilepsy remains unclear. This study aimed to evaluate the genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shitao, Cai, Xuemei, Liu, Shiyong, Zhou, Qixin, Wang, Ting, Du, Sunbing, Wang, Dan, Yang, Fei, Wu, Qian, Han, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780294/
https://www.ncbi.nlm.nih.gov/pubmed/36568279
http://dx.doi.org/10.3389/fnmol.2022.1010101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780294/
https://www.ncbi.nlm.nih.gov/pubmed/36568279
http://dx.doi.org/10.3389/fnmol.2022.1010101

Ejemplares similares